These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9454312)

  • 21. [Modern treatment of rheumatoid arthritis].
    Surányi P
    Orv Hetil; 2005 Oct; 146(40):2059-65. PubMed ID: 16259334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What are the costs to society and the potential benefits from the effective management of early rheumatoid arthritis?
    March L; Lapsley H
    Best Pract Res Clin Rheumatol; 2001 Mar; 15(1):171-85. PubMed ID: 11358421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of early rheumatoid arthritis.
    Brown AN
    J S C Med Assoc; 2003 Oct; 99(10):296-302. PubMed ID: 14621660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatoid arthritis in dermatology.
    Hata T; Kavanaugh A
    Clin Dermatol; 2006; 24(5):430-7. PubMed ID: 16966022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-drug and non-surgical measures in chronic polyarthritis].
    Rey B
    Ther Umsch; 1991 Sep; 48(9):624-31. PubMed ID: 1948774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS
    Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early rheumatoid arthritis: strategies for prevention and management.
    Combe B
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of rheumatoid arthritis and access to treatment: a medical overview.
    Smolen J; Aletaha D
    Eur J Health Econ; 2008 Jan; 8 Suppl 2():S39-47. PubMed ID: 18157733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis: initial experience in 12 patients.
    Gremillion RB; Posever JO; Manek N; West JP; van Volen-Hoven RF
    J Rheumatol; 1999 Nov; 26(11):2332-6. PubMed ID: 10555886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2008 Apr; 14(4):234-54. PubMed ID: 18415967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonpharmacological interventions for the treatment of rheumatoid arthritis: a focus on mind-body medicine.
    Leverone D; Epstein BJ
    J Pharm Pract; 2010 Apr; 23(2):101-9. PubMed ID: 21507802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S237-51. PubMed ID: 18095787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologics in rheumatoid arthritis.
    Sharma PK; Hota D; Pandhi P
    J Assoc Physicians India; 2004 Mar; 52():231-6. PubMed ID: 15636315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of medications used in juvenile rheumatoid arthritis.
    Guthrie B; Rouster-Stevens KA; Reynolds SL
    Pediatr Emerg Care; 2007 Jan; 23(1):38-46. PubMed ID: 17228221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of a sixteen-week training program on strength, pain, and function in rheumatoid arthritis patients.
    Flint-Wagner HG; Lisse J; Lohman TG; Going SB; Guido T; Cussler E; Gates D; Yocum DE
    J Clin Rheumatol; 2009 Jun; 15(4):165-71. PubMed ID: 19279507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.
    Stone M; Fortin PR; Pacheco-Tena C; Inman RD
    J Rheumatol; 2003 Oct; 30(10):2112-22. PubMed ID: 14528503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are biological targets the final goal for rheumatoid arthritis therapy?
    Sharma P; Pathak K
    Expert Opin Biol Ther; 2012 Dec; 12(12):1611-22. PubMed ID: 22954024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination treatment strategies in early rheumatoid arthritis.
    Suresh E; Lambert CM
    Ann Rheum Dis; 2005 Sep; 64(9):1252-6. PubMed ID: 15860511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.